Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges

被引:44
|
作者
Solomon, D. H. [1 ,2 ]
Mercer, E. [2 ]
Woo, S. B. [3 ,4 ]
Avorn, J. [1 ]
Schneeweiss, S. [1 ]
Treister, N. [3 ,4 ]
机构
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Oral Med, Boston, MA 02115 USA
关键词
Bisphosphonate; Epidemiology; Osteonecrosis of the jaw; Osteoporosis; ORAL BISPHOSPHONATES; SURGERY; PREVALENCE;
D O I
10.1007/s00198-012-2042-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bisphosphonate-related osteonecrosis of the jaw (BONJ) is an adverse effect of bisphosphonate use with a poorly described epidemiology in osteoporosis patients. We examined the literature and two new cohorts for BONJ. The literature suggests an incidence rate of 0.028 % to 4.3 %. Our cohort studies found an incidence of 0.02 % (95 % CI 0.004 %-0.11 %). We examined the epidemiology of BONJ associated with osteoporosis dosing of bisphosphonates. First, we systematically searched the literature about osteoporosis BONJ. Identified studies were abstracted by two authors. Second, we attempted to estimate the relative risk of BONJ among bisphosphonate users with osteoporosis. Two different large insurance databases, one from 2005-2007 and another from 2007-2010, combined with medical record review, were searched. The older dataset did not include the International Classification of Diagnoses (ICD) diagnosis code for osteonecrosis of the jaw (ONJ; ICD 733.45). Incidence rates and relative risks were estimated using Cox regression. The literature review produced nine studies of varying quality. The incidence rates for BONJ among osteoporosis patients varied from 0.028 % to 4.3 %. Two prior studies estimated the relative risk of ONJ related to bisphosphonates and found odds ratios of 7.2 and 9.2. Our attempts to estimate the incidence rate of BONJ encompassed 41,957 in the dataset from 2005-2007 and 466,645 in a separate dataset from 2007-2010. From the older dataset, we found 51 potential cases of BONJ using a broad definition of possible ONJ. One case was confirmed by a dentist for a prevalence of 0.02 % (95 % CI 0.004 %-0.11 %) among bisphosphonate users. From the newer dataset, we found 13 possible cases, but none could be confirmed. Most subjects with the ONJ diagnosis code appeared to have had an osteoporosis-related fracture and not ONJ. The literature suggests a broad range of possible values for the prevalence of BONJ; our estimate fell within the range from prior literature.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 50 条
  • [21] Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management
    Dupic, Guillaume
    Collangettes, Denise
    Dillies, Anne-Francoise
    Calvet, Laure
    Tournilhac, Olivier
    Bay, Jacques-Olivier
    Mahammedi, Hakim
    BULLETIN DU CANCER, 2015, 102 (12) : 1010 - 1019
  • [22] Bisphosphonate-Associated Osteonecrosis of the Jaw: Are We Dealing with a Localized Non-Traditional Calciphylaxis?
    Meiller, T. F.
    Almubarak, H.
    Weikel, D. S.
    Brahim, J.
    Scheper, M. A.
    OPEN DENTISTRY JOURNAL, 2012, 6 : 5 - 7
  • [24] A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution
    Subramanian, Gayathri
    Cohen, Harold V.
    Quek, Samuel Y. P.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2011, 112 (06): : 744 - 753
  • [25] Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research
    Khosla, Sundeep
    Burr, David
    Cauley, Jane
    Dempster, David W.
    Ebeling, Peter R.
    Felsenberg, Dieter
    Gagel, Robert F.
    Gilsanz, Vincente
    Guise, Theresa
    Koka, Sreenivas
    McCauley, Laurie K.
    McGowan, Joan
    Mckee, Marc D.
    Mohla, Suresh
    Pendrys, David G.
    Raisz, Lawrence G.
    Ruggiero, Salvatore L.
    Shafer, David M.
    Shum, Lillian
    Silverman, Stuart L.
    Van Poznak, Catherine H.
    Watts, Nelson
    Woo, Sook-Bin
    Shane, Elizabeth
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (10) : 1479 - 1491
  • [26] Correlating the Prevalence of bisphosphonate-associated Osteonecrosis of the Jaw with the Duration of Onset of Bisphosphonates in Tumor and Osteoporosis Patients? Overall Evaluation of the German Osteonecrosis of the Jaw Registry
    Karberg, Niels
    Felsenberg, Dieter
    JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2020, 27 (01): : 8 - 18
  • [27] Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw - work in progress and challenges
    Schiodt, Morten
    Wexell, Cecilia Larsson
    Herlofson, Bente Brokstad
    Giltvedt, Karen Marie
    Norholt, Sven Erik
    Ehrenstein, Vera
    CLINICAL EPIDEMIOLOGY, 2015, 7 : 107 - 116
  • [28] Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: Technical report and follow up of 21 patients
    Voss, Pit Jacob
    Oshero, Joel Joshi
    Kovalova-Mueller, Alice
    Merino, Egle Alina Veigel
    Sauerbier, Sebastian
    Al-Jamali, Jamil
    Lemound, Juliana
    Metzger, Marc Christian
    Schmelzeisen, Rainer
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2012, 40 (08) : 719 - 725
  • [29] Uncertainty of Current Algorithm for Bisphosphonate-Related Osteonecrosis of the Jaw in Population-Based Studies: a Systematic Review
    Kim, Hye-Yeon
    Kim, Jin-Woo
    Kim, Sun-Jong
    Lee, Sang-Hwa
    Lee, Hong-Soo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (03) : 584 - 591
  • [30] INCIDENCE AND RISK FACTORS OF BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAWS
    Stumpe, Matthew R.
    Chandra, Rakesh K.
    Yunus, Furhan
    Samant, Sandeep
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (02): : 202 - 206